Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
175 USD | +9,83% | +9,83% | -11,17% |
14/06 | NICE LTD. : Morgan Stanley handhaaft koopadvies | ZM |
12/06 | NICE LTD. : RBC Capital Markets handhaaft koopadvies | ZM |
Omzet 2024 * | 2,72 mld. 2,54 mld. | Omzet 2025 * | 3,05 mld. 2,85 mld. | Marktkapitalisatie | 10,98 mld. 10,26 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 449 mln. 420 mln. | Nettowinst (verlies) 2025 * | 543 mln. 507 mln. | EV/omzet 2024 * | 3,49 x |
Nettoliquiditeiten 2024 * | 1,47 mld. 1,38 mld. | Nettoliquiditeiten 2025 * | 2,28 mld. 2,13 mld. | EV/omzet 2025 * | 2,85 x |
K/w-verhouding 2024 * |
24,9
x | K/w-verhouding 2025 * |
19,3
x | Werknemers | 8.384 |
Dividendrendement 2024 * |
0,02% | Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
1 dag | +9,83% | ||
1 week | +9,83% | ||
Lopende maand | -10,71% | ||
1 maand | -20,38% | ||
3 maanden | -28,57% | ||
6 maanden | -11,17% | ||
Lopend jaar | -11,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
12-06-24 | 175 | +9,83% | 3 |
uitgestelde koers OTC Markets, 12 juni 2024 om 20:23 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,62% | 90,43 mld. | |
+14,59% | 85,57 mld. | |
+37,27% | 52,49 mld. | |
-19,27% | 50,25 mld. | |
+32,93% | 46,79 mld. | |
+83,75% | 42,74 mld. | |
-32,70% | 41,67 mld. | |
-1,24% | 27,82 mld. | |
-23,23% | 22,46 mld. |
- Beurs
- Aandelen
- Koers NICE
- Koers NCSYF